BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9667661)

  • 1. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
    Obermair A; Tempfer C; Hefler L; Preyer O; Kaider A; Zeillinger R; Leodolter S; Kainz C
    Br J Cancer; 1998 Jun; 77(11):1870-4. PubMed ID: 9667661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK; Caffier H
    Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR
    Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
    Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
    Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
    Oehler MK; Caffier H
    Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients.
    Abendstein B; Daxenbichler G; Windbichler G; Zeimet AG; Geurts A; Sweep F; Marth C
    Anticancer Res; 2000; 20(1B):569-72. PubMed ID: 10769727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the serum concentration of vascular endothelial growth factor (VEGF) and hemoglobin levels in patients with epithelial ovarian cancer.
    Obermair A; Hefler L; Nather A; Preyer O; Kaider A
    Ann Oncol; 1999 Aug; 10(8):998. PubMed ID: 10509167
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D; Nicosia RF; Nicosia SV
    Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies.
    Dehaven K; Taylor DD; Gercel-Taylor C
    Int J Gynecol Cancer; 2002; 12(6):715-9. PubMed ID: 12445248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do preoperative serum vascular endothelial growth factor and migration-inhibitory factor predict the nature of the adnexal masses? A prospective-controlled trial.
    Yildirim N; Dikmen Y; Terek MC; Akman L; Gunel NS; Aktan C; Zekioglu O; Gunduz C
    J Obstet Gynaecol; 2016 May; 36(4):533-7. PubMed ID: 26758243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.